Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03765814
Other study ID # 2018-CHITS-02
Secondary ID 2018-A01455-50
Status Recruiting
Phase
First received
Last updated
Start date September 29, 2019
Est. completion date September 28, 2024

Study information

Verified date March 2024
Source Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Contact Asmaa Jobic
Phone 04.83.77.20.61
Email asmaa.jobic@ch-toulon.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to make a paramedical evaluation of a selection procedure of serious brain-injured patient in therapeutic abstention to a brain death state within 48 hours.


Description:

In 2016 in France, 5891 organs have been transplanted. All the transplant's sources are developed (brain death, Maastricht III, living organ donor). However, the French Transplant's plan 2017-2021 require always more transplant, the aim is to reach 7800 transplants in 4 years. To increase the number of transplants, one of the strategies is to actively identify the donors in brain death state and the donors with wider criteria. It's mainly serious brain-injured patients. The procedure of early announcement of organ donation consists in beginning or pursues intensive care on serious brain-injured patient, for whom a decision of abstention of therapeutic active was decided. The only purpose of the medical care is to notice the brain death state that lead to donation. In 2010, an expert group of the "Société de reanimation de langue Française" established guidelines to manage organ's donation in serious brain-injured patient after a stroke. The interest, to admit these serious brain-injured patients in intensive care unit, is to increase the number of donors in state of brain death and so the number of transplants. However the guidelines remain little practised and little known in France. The number of bed in intensive care unit is limited and requires a selection of the potential organ donors. To hospitalised serious brain-injured patients in intensive care unit, there are no validated selection criteria that make difficult the implication of the transplant coordination in this anticipated announcement's approach. In Toulon hospital, a standardize selection procedure was initiated and applied systematically by the transplant coordinator for each serious brain-injured patients. The selected patients will evolve in brain death state in 48 hours and could be organ donors. The aim of this study is to validate a paramedical procedure to increase the number of organ donors.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date September 28, 2024
Est. primary completion date September 28, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Male or Female over 18 years-old - Patient with serious brain damages - Medical decision of withdrawing life sustaining treatment - Signed and dated informed consent by trusted person, or family - Patient covered by social security regimen - Patient eligible for organ donation according to organ donation hospital co-ordination - Glasgow Coma Scale (GCS) : - Seriously brain-injured patient without confounding factors, head trauma, brain anoxia or ischemic stroke : GCS<5 and loss of bilateral corneal reflex or GCS<5 and loss of three brain stem reflexes - Seriously brain-injured patient with confounding factors and without head trauma, brain anoxia or ischemic stroke : at least one of the following scanographic sign of gravity : deletion of subarachnoid cisterns, more than 15 mm deviation of the median line, hematoma volume > 65 cm3 or hydrocephalus due to intra-ventricular bleeding with V3 or V4 flood, and, if documented, a GCS<7. - Patient with head trauma, brain anoxia or ischemic stroke, reliable clinical examination required (no confounding factor) : GCS<5 and loss of bilateral corneal reflex or GCS<5 and loss of three brain stem reflexes Exclusion Criteria: - No trusted person or family present - Seriously brain-injured patient because of head trauma, brain anoxia or ischemic stroke with confounding factors - Absolute contraindication to organ donation known at the moment of inclusion (HIV, rabies, active cancer, active tuberculosis, Creutzfeldt-Jakob disease)

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Centre Hospitalier Départemental de Vendée Les Oudairies La Roche-sur-Yon Vendée
France CHU de Nantes Nantes Loire-Atlantique
France CH Annecy Genevois Pringy Haute Savoie
France Centre Hospitalier Intercommunal Toulon La Seyne sur Mer Toulon Var

Sponsors (2)

Lead Sponsor Collaborator
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer Centre Hospitalier Universitaire de Nice

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Study of the evolution to brain death state within 48 hours of seriously brain-injured patients selected by a standardized procedure and hospitalised in intensive care unit. Rate of patients evolving to brain death state during the first 48 hours following the examination which validates patient's eligibility 48 hours after validation of eligibility
Secondary Evaluation of call rate to transplant coordination that don't result in a procedure of anticipated announcement Ratio between the number of non-eligible patients and the total number of calls 48 hours after validation of eligibility
Secondary Evaluation of close family refusal rate for pursuit of care during 48h in intensive care unit Ratio between the number of family refusal and the total number of patients for whom the anticipated announcement procedure was started. 48 hours after validation of eligibility
Secondary Number of refusal causes in the population Number of refusal causes will be presented globally 48 hours after validation of eligibility
Secondary Evaluation of the delay between eligibility validation and the passage in brain death state. The passage delay between eligibility validation and brain death state is defined by the time in hours between the examination which validates patient's eligibility and the diagnosis of brain death state. 48 hours after validation of eligibility
Secondary Evaluation of the rate of patients with organ removal in enrolled patients. Ratio between the number of patient who performed organ donation and the total number of patients included. 48 hours after validation of eligibility
Secondary Number and type of organ harvested by patient. Number of organs collected will be presented globally, by patient and by type of organ transplanted. 48 hours after validation of eligibility
Secondary Number of transplants performed. The number of transplants performed will be presented globally, by patient and by type of organs. 10 days
Secondary Number of patient enrolled by type of service. The number of patient enrolled in the intensive care unit, the Emergency or Neurovascular intensive care unit will be described globally 48 hours after validation of eligibility
Secondary Non harvested organs which have been suggested for transplant The proportion of suggested non harvested organs will be determined as the number of suggested non harvested organs divided by the total number of non harvested organs. Reasons of suggested organs refusal will be presented. 10 days
Secondary Number of patients who performed Maastricht 3 organ donation among patients who didn't evolve to brain death state The rate of patients with Maastricht 3 organ donation will be determined as the number of patients having performed Maastricht 3 organ donation divided by the number of patients who didn't evolve to brain death state after 48hours 10 days
See also
  Status Clinical Trial Phase
Completed NCT02581111 - Naloxone for Optimizing Hypoxemia Of Lung Donors Phase 2/Phase 3
Completed NCT00808691 - Microcirculation and Oxidative Stress in Critical Ill Patients in Surgical Intensive Care Unit N/A
Completed NCT00998972 - N-acetyl-cysteine (NAC) and Kidney Graft Function Phase 3
Completed NCT04528797 - Thyroid and Adrenocortical Hormone Replacement in Organ Donors N/A
Completed NCT03672812 - The Use of Liraglutide in Brain Death Phase 3
Completed NCT04303624 - Understanding Family Refusal
Completed NCT03098706 - Therapeutic Hypothermia in "Expanded Criteria" Brain-dead Donors and Kidney-graft Function N/A
Not yet recruiting NCT04623294 - Online Noninvasive Assessment of Human Brain Death and Deep Coma by Near-infrared Spectroscopy
Recruiting NCT02102945 - Special Imaging Technique to Aid in the Diagnosis of Patients in Coma After Cardiac Arrest N/A
Completed NCT02483273 - Alterations of Conjunctival Microcirculation in Brain Dead Patients N/A
Terminated NCT00675272 - Organ Donation and Hydrocortisone Treatment N/A
Completed NCT03262896 - Neurophysiological Examination in Patients With Brain Death
Not yet recruiting NCT06359119 - Implementation of Apnoea Test for Patients With Suspected Brain Death
Recruiting NCT05202886 - "LiverColor": Machine Learning in Liver Photographs N/A
Completed NCT03281993 - Apnea Tests as the Methods of Brain Death Diagnosis. N/A
Completed NCT03179020 - Donation Network to Optimize Organ Recovery Study N/A
Completed NCT05070182 - Resting Energy Needs in Brain Dead Patients (reSting EneRgy nEeds iN brAin DEad Patients)
Terminated NCT03439995 - Goal of Open Lung Ventilation in Donors N/A
Completed NCT02525510 - Deceased Organ Donor Interventions to Protect Kidney Graft Function N/A
Completed NCT02742857 - Non-randomized, Open-labeled, Interventional, Single Group, Proof of Concept Study With Multi-modality Approach in Cases of Brain Death Due to Traumatic Brain Injury Having Diffuse Axonal Injury Phase 1